Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adverse Drug Reactions to Antituberculosis Drugs in the Treatment of Latent Tuberculosis Infection in Korean Health Care Workers

NCT03312647 is registered in ClinicalTrials.gov with Hanyang University as lead sponsor.

NCT NCT03312647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03312647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adverse Drug Reactions to Antituberculosis Drugs in the Treatment of Latent Tuberculosis Infection in Korean Health Care Workers
Lead sponsor
Hanyang University
Phase
Observational
Overall status
Unknown status
Start date
June 19, 2017
Completion date
May 31, 2018
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

latent tuberculosis infection